Yahoo India Web Search

Search results

  1. 3 days ago · Drishti IAS English presents to you a daily programme, To The Point, - covering all relevant and important topics from UPSC and state PSC points of view. In ...

    • 5 min
    • 7
    • Drishti IAS : English
  2. 2 days ago · What is Radical CAR-T Therapy? Car-T therapy, which is also called “chimeric antigen receptor T-cell” therapy, is a new and innovative way to treat cancer. Recently, in November 2023, the US Food and Drug Administration (FDA) began looking into whether Car-T therapy could cause new types of cancer. By March 2024, the FDA had found 33 cases ...

  3. 3 days ago · Car-T therapy, short for “chimeric antigen receptor T-cell”, is a cutting-edge treatment that reprogrammes a patient’s immune cells to fight their cancer. This innovative approach involves ...

  4. 5 days ago · CRISPR is advancing CAR T therapy. Here are three ways that CRISPR is helping make the next generation of CAR therapies: Multispecific antigen sensing: CAR T cells targeting CD19, an antigen found in lymphomas and leukemias, represent the majority of clinical trials utilizing CAR technology.

  5. The promising findings, reported today in Science Advances, involve CAR-T cell therapy, which supercharges the immune system to identify and attack cancer cells. “CAR-T cell therapy has revolutionized the treatment of blood cancers such as leukemia and lymphoma but hasn’t worked well against solid tumors,” said Xingxing Zang, Ph.D. , the ...

  6. 5 days ago · Even before Tuesday’s positive readout, Carvykti had in April won the FDA’s approval as a second-line therapy for multiple myeloma based on CARTITUDE-4 data showing the BCMA-targeted CAR-T can ...

  7. People also ask

  8. 3 days ago · OK, so a CAR T-cell therapy, comes back to that Trojan horse analogy. So we know that our immune system has the capability of recognizing cancer, but sometimes it doesn't do a great job or we wouldn't develop cancer. So with CAR T-cell therapy, CAR stands for chimerical antigen receptor.